Our History

For more than 75 years, Ortho has been guided by its purpose: to improve and save lives with diagnostics. Review our timeline to discover important moments throughout our rich history of pioneering life-impacting advances.  


Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISION™ Analyzer, making it commercially available in the United States. ORTHO VISION™ Analyzer automates the full range of immunohematology testing and helps improve the safety of blood transfusions by reducing the lab's reliance on manual methods
The Carlyle Group acquires Ortho Clinical Diagnostics from Johnson & Johnson
Ortho Clinical Diagnostics logo
Ortho Clinical Diagnostics launches ORTHO™ Workstation, a next-generation semi-automated blood typing system
ORTHO™ Workstation
Ortho Clinical Diagnostics launches the VITROS® 4600 Chemistry System for mid- to high-volume laboratories
VITROS<sup>®</sup> 4600 Chemistry System
Ortho Clinical Diagnostics launches the VITROS® 5600 Integrated System, which integrates clinical chemistry and immunoassay testing, and the VITROS® 3600 Immunodiagnostic System
VITROS<sup>®</sup> 5600 Integrated System
Ortho Clinical Diagnostics launches the first FDA-licensed test to screen blood donations for exposure to Chagas' disease
Ortho Clinical Diagnostics launches the VITROS® 350 Chemistry System
VITROS<sup>®</sup> 350 Chemistry System
Ortho Clinical Diagnostics launches the VITROS® 5, 1 FS Chemistry System, raising industry standards for ease-of-use, integrity of results, and operational efficiency
VITROS<sup>®</sup> 5, 1 FS Chemistry System
Ortho Clinical Diagnostics launches the VITROS® ECiQ Immunodiagnostic System and the ORTHO AutoVue® Innova System
VITROS<sup>®</sup> ECiQ Immunodiagnostic System and ORTHO AutoVue<sup>®</sup> Innova System
Ortho Clinical Diagnostics launches ORTHO ProVue® Analyzer, the first fully automated immunohematology system for use with the ID-Micro Typing System™ (ID-MTS) Gel Test in North America
ORTHO ProVue<sup>®</sup> Analyzer
Ortho Clinical Diagnostics acquires Micro Typing Systems of Pompano Beach, Florida, the manufacturer of the ID-Micro Typing System™ (ID-MTS) used in hospitals and donor centers to help to ensure safe and effective blood transfusions
ID-Micro Typing System™ (ID-MTS)
Ortho Clinical Diagnostics becomes the first diagnostic company to receive US FDA approval for automated random access hepatitis tests, on the VITROS® ECi Immunodiagnostic System (for diagnostic use only; not for blood screening)
Ortho Clinical Diagnostics develops Ortho trak-C™, the world’s first branded “Total HCV Core Antigen” test designed to provide reliable measures of HCV viremia
Ortho Clinical Diagnostics releases the HCV Core Antigen ELISA Test System—the first test commercially available for the direct detection in blood and plasma of HCV core antigen, a marker of early infection in hepatitis C–infected individuals
HCV Core Antigen ELISA Test System
Ortho Clinical Diagnostics becomes one of the first diagnostic industry suppliers to offer contracted implementation services that can significantly reduce clinical laboratory costs through operational efficiencies and streamlined processes
Ortho Clinical Diagnostics introduces the ORTHO AutoVue® System, the first fully automated blood banking system in Europe
ORTHO AutoVue<sup>®</sup> System
Ortho Clinical Diagnostics is formed from the merger of two Johnson & Johnson companies: Ortho Diagnostic Systems, a worldwide leader in transfusion medicine reagents and instrument systems, and Johnson & Johnson Clinical Diagnostics (formerly a division of Eastman Kodak Co.), a worldwide leader in clinical laboratory systems
Ortho Clinical Diagnostics Johnson & Johnson logo
Ortho Products introduces the most advanced immunodiagnostic system available in the industry, the VITROS® ECi Immunodiagnostic System
Ortho Clinical Diagnostics introduces the Ortho Summit™ System, the first fully automated blood and plasma screening system available in the US
Ortho Summit™ System
Ortho Products introduces the first test for the detection of antibodies to hepatitis C
Ortho Products introduces patented thin-film dry slide technology, once again revolutionizing the field of diagnostics by providing clinical professionals with the means to receive high-quality results quickly, cleanly, and economically
Ortho Clinical Diagnostics dry slide technology
Ortho Products develops the first blood bank anti-D test for the clinical market. This is a revolutionary advance in the burgeoning blood banking industry.
Dr. Philip Levine, a pioneer in the field of hematology, joins Ortho Products to continue his breakthrough research into the mechanics of the Rh system in human blood. This marks the beginning of the company's commitment to diagnostic medicine. Among Dr. Levine's many contributions is research that leads to the development of Rh immune globulin to protect Rh-negative women against isoimmunization, saving the lives of thousands of babies.
Dr. Philip Levine
Ortho Products, Inc., is formed in Linden, New Jersey, as a division of Johnson & Johnson